| answer text |
<p>Developing new diagnostics that enable early detection of bacterial or viral infections
and drive optimal antimicrobial usage is a priority for this Government. Since 2014,
the Government has invested over £360 million in antimicrobial resistance research
and development, including funding to support the development of diagnostics for infection.</p><p>Investments
in early-stage funding for diagnostic research include the £10 million Longitude Prize
for a diagnostic tool that can rule out antibiotic use or help identify an effective
antibiotic to treat a patient. The National Institute for Health Research Medtech
and In Vitro Diagnostic Co-operatives support the development of medical technology
and the uptake of commercially supplied in vitro diagnostic devices, including for
infection-related tests. The £14.25 million award is for five years until 2022.</p>
|
 |
